Baxter ROA 2006-2019 | BAX

Current and historical return on assets (ROA) values for Baxter (BAX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Baxter ROA for the three months ending June 30, 2019 was 10.36%.
Baxter ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-06-30 $1.58B $17.54B 9.53%
2019-03-31 $1.58B $16.35B 9.67%
2018-12-31 $1.62B $15.64B 9.85%
2018-09-30 $1.21B $16.85B 7.15%
2018-06-30 $0.91B $16.58B 5.36%
2018-03-31 $0.83B $16.89B 4.87%
2017-12-31 $0.72B $17.11B 4.26%
2017-09-30 $1.03B $17.54B 6.28%
2017-06-30 $0.91B $16.96B 5.69%
2017-03-31 $1.86B $15.66B 11.79%
2016-12-31 $4.97B $15.55B 30.71%
2016-09-30 $4.93B $15.80B 28.12%
2016-06-30 $4.80B $15.98B 25.77%
2016-03-31 $3.92B $17.35B 17.71%
2015-12-31 $0.97B $20.96B 4.03%
2015-09-30 $1.72B $20.17B 6.78%
2015-06-30 $2.18B $30.02B 8.19%
2015-03-31 $2.37B $24.86B 9.28%
2014-12-31 $2.50B $26.14B 9.74%
2014-09-30 $1.87B $25.56B 7.36%
2014-06-30 $1.95B $25.63B 7.68%
2014-03-31 $2.02B $25.26B 8.11%
2013-12-31 $2.01B $25.22B 8.51%
2013-09-30 $2.18B $25.25B 9.72%
2013-06-30 $2.22B $23.75B 10.53%
2013-03-31 $2.29B $20.32B 11.60%
2012-12-31 $2.33B $20.39B 12.01%
2012-09-30 $2.30B $19.83B 12.06%
2012-06-30 $2.29B $18.45B 12.34%
2012-03-31 $2.24B $18.78B 12.21%
2011-12-31 $2.22B $19.07B 12.34%
2011-09-30 $2.18B $17.84B 12.39%
2011-06-30 $2.13B $17.74B 12.15%
2011-03-31 $2.05B $17.41B 11.91%
2010-12-31 $1.42B $17.49B 8.27%
2010-09-30 $1.57B $17.56B 9.15%
2010-06-30 $1.57B $16.49B 9.26%
2010-03-31 $1.63B $17.17B 9.68%
2009-12-31 $2.21B $17.35B 13.57%
2009-09-30 $2.20B $16.95B 13.97%
2009-06-30 $2.14B $15.74B 13.99%
2009-03-31 $2.10B $14.95B 13.77%
2008-12-31 $2.01B $15.41B 13.19%
2008-09-30 $1.92B $15.21B 12.62%
2008-06-30 $1.85B $15.47B 12.33%
2008-03-31 $1.73B $14.97B 11.73%
2007-12-31 $1.71B $15.29B 11.66%
2007-09-30 $1.66B $14.15B 11.46%
2007-06-30 $1.64B $14.66B 11.36%
2007-03-31 $1.52B $14.48B 10.82%
2006-12-31 $1.40B $14.69B 10.27%
2006-09-30 $1.26B $13.93B 9.59%
2006-06-30 $1.00B $13.01B 7.64%
2006-03-31 $1.01B $12.78B 7.65%
2005-12-31 $0.96B $12.73B 7.09%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $44.403B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.840B 28.17
Medtronic (MDT) Ireland $137.817B 19.69
Stryker (SYK) United States $81.180B 28.07
Boston Scientific (BSX) United States $58.714B 28.48
EssilorLuxottica Societe Anonyme (ESLOY) France $30.829B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.130B 18.00
Coloplast (CLPBY) Denmark $26.395B 42.14
Lonza Group Ag (LZAGY) Switzerland $26.038B 0.00
Terumo (TRUMY) Japan $23.788B 27.35
Smith & Nephew SNATS (SNN) United Kingdom $20.267B 0.00
ResMed (RMD) United States $19.315B 36.83
Sunny Optical Technology (SNPTF) China $13.689B 0.00
Bio-Rad Laboratories (BIO) United States $9.759B 52.32
Canopy Growth (CGC) Canada $9.745B 0.00
Insulet (PODD) United States $9.055B 536.57
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Haemonetics (HAE) United States $7.033B 53.07
Hill-Rom Holdings (HRC) United States $7.032B 20.97
Perrigo (PRGO) Ireland $6.283B 11.57
Aurora Cannabis (ACB) Canada $6.094B 59.90
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
GW Pharmaceuticals (GWPH) United Kingdom $4.651B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.710B 61.70
ICU Medical (ICUI) United States $3.430B 22.25
NuVasive (NUVA) United States $3.316B 26.44
Hutchison China MediTech (HCM) China $2.737B 0.00
Quidel (QDEL) United States $2.552B 25.34
Agios Pharmaceuticals (AGIO) United States $2.491B 0.00
National Vision Holdings (EYE) United States $2.177B 46.98
Cardiovascular Systems (CSII) United States $1.682B 0.00
Aphria (APHA) $1.551B 0.00
Phibro Animal Health (PAHC) United States $1.263B 18.92
AtriCure (ATRC) United States $1.060B 0.00
VAREX IMAGING (VREX) United States $1.018B 23.45
NanoString Technologies (NSTG) United States $0.977B 0.00
Omeros (OMER) United States $0.967B 0.00
PetIQ (PETQ) United States $0.908B 21.44
Lantheus Holdings (LNTH) United States $0.897B 23.57
Eagle Pharmaceuticals (EGRX) United States $0.794B 20.23
Cerus (CERS) United States $0.769B 0.00
MacroGenics (MGNX) United States $0.737B 0.00
Quanterix (QTRX) United States $0.702B 0.00
TG Therapeutics (TGTX) United States $0.648B 0.00
LeMaitre Vascular (LMAT) United States $0.626B 37.08
Surmodics (SRDX) United States $0.601B 114.26
OraSure Technologies (OSUR) United States $0.446B 20.63
Meridian Bioscience (VIVO) United States $0.432B 13.48
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.423B 0.00
BioLife Solutions (BLFS) United States $0.376B 123.63
United Health Products (UEEC) United States $0.350B 0.00
Utah Medical Products (UTMD) United States $0.349B 25.56
Zynex (ZYXI) United States $0.345B 36.62
Owens & Minor (OMI) United States $0.306B 9.17
Bovie Medical (APYX) United States $0.251B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Cytosorbents (CTSO) United States $0.155B 0.00
Chimerix (CMRX) United States $0.153B 0.00
Fonar (FONR) United States $0.152B 8.01
Rockwell Medical (RMTI) United States $0.152B 0.00
Female Health (VERU) United States $0.123B 0.00
InfuSystems Holdings (INFU) United States $0.099B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
United-Guardian (UG) United States $0.087B 20.65
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Surface Oncology (SURF) United States $0.055B 0.00
Nephros (NEPH) United States $0.054B 0.00
MRI INTERVENTNS (MRIC) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.041B 14.17
Senestech (SNES) United States $0.039B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Myomo (MYO) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00